124 results on '"GOLDSTEIN, MATTHEW"'
Search Results
2. Trends in sedation‐analgesia practices in pediatric liver transplant patients admitted postoperatively to the pediatric intensive care unit: An analysis of data from the pediatric health information system (PHIS) database
3. A blistering rash and lymphadenopathy in a toddler
4. Unique Rhythm Phenomena and Mechanisms
5. Data from Adoptive Cell Therapy for Lymphoma with CD4 T Cells Depleted of CD137-Expressing Regulatory T Cells
6. Data from Adoptive Cell Therapy for Lymphoma with CD4 T Cells Depleted of CD137-Expressing Regulatory T Cells
7. Supplementary Figure 1 from Adoptive Cell Therapy for Lymphoma with CD4 T Cells Depleted of CD137-Expressing Regulatory T Cells
8. Supplementary Figure 1 from Adoptive Cell Therapy for Lymphoma with CD4 T Cells Depleted of CD137-Expressing Regulatory T Cells
9. Supplementary Figure Legends 1-4 from Adoptive Cell Therapy for Lymphoma with CD4 T Cells Depleted of CD137-Expressing Regulatory T Cells
10. Supplementary Figure 2 from Adoptive Cell Therapy for Lymphoma with CD4 T Cells Depleted of CD137-Expressing Regulatory T Cells
11. Supplementary Figure 3 from Adoptive Cell Therapy for Lymphoma with CD4 T Cells Depleted of CD137-Expressing Regulatory T Cells
12. Supplementary Figure 3 from Adoptive Cell Therapy for Lymphoma with CD4 T Cells Depleted of CD137-Expressing Regulatory T Cells
13. Supplementary Figure 4 from Adoptive Cell Therapy for Lymphoma with CD4 T Cells Depleted of CD137-Expressing Regulatory T Cells
14. Supplementary Figure 2 from Adoptive Cell Therapy for Lymphoma with CD4 T Cells Depleted of CD137-Expressing Regulatory T Cells
15. Supplementary Figure 4 from Adoptive Cell Therapy for Lymphoma with CD4 T Cells Depleted of CD137-Expressing Regulatory T Cells
16. Supplementary Figure Legends 1-4 from Adoptive Cell Therapy for Lymphoma with CD4 T Cells Depleted of CD137-Expressing Regulatory T Cells
17. 1425 In vivo CRISPR screens identify HDAC1 as an immune sensitizer reversing immune resistance driven by STK11 loss
18. Abstract 3941: TNG908 is an MTAPnull-selective PRMT5 inhibitor that drives tumor regressions in MTAP-deleted xenograft models across multiple histologies
19. Femoral nerve neuromonitoring for lateral lumbar interbody fusion surgery
20. Abstract P214: MTAPnull-selective PRMT5 inhibitors drive regressions in MTAP-deleted xenograft models across histologies
21. Academic Freedom
22. 12. Academic Freedom: Some Considerations
23. Abstract 1905:In vivoCRISPR screen identifies tumor suppressors as drivers of tumor cell-intrinsic immune evasion
24. Intralesional cryotherapy with triamcinolone and onabotulinumtoxinA injections for umbilical keloid: A case report
25. 1124: Utilizing a Standardized Pain and Agitation Protocol for Intubated Patients in the Pediatric ICU
26. Optimizing the Therapeutic Window of Targeted Drugs in Oncology: Potency‐Guided First‐in‐Human Studies
27. 850: EVALUATION OF THE SAFETY OF RISPERIDONE IN TREATING DELIRIUM IN CRITICALLY ILL CHILDREN
28. Improved resolution of mixed STR profiles using a fully automated differential cell lysis/DNA extraction method
29. PKC induces release of a functional ectodomain of the guidance cue semaphorin6A
30. Abstract 942: The personalized vaccine, NEO-PV-01 with anti-PD1, induces neoantigen-specific de novo immune responses in patients with advanced metastatic melanoma: Association with clinical outcomes
31. Abstract 5006: Comprehensive gene expression analysis of the tumor microenvironment in patients with advanced cancer treated with a personalized neoantigen vaccine, NEO-PV-01, in combination with anti-PD1
32. Abstract 5006: Comprehensive gene expression analysis of the tumor microenvironment in patients with advanced cancer treated with a personalized neoantigen vaccine, NEO-PV-01, in combination with anti-PD1
33. Abstract 942: The personalized vaccine, NEO-PV-01 with anti-PD1, induces neoantigen-specific de novo immune responses in patients with advanced metastatic melanoma: Association with clinical outcomes
34. Does Metformin Have an Effect on Stent Patency Rates
35. Targeting CD137 enhances the efficacy of cetuximab
36. Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer
37. Abstract LB-147: Comprehensive immune and molecular analysis of two metastatic melanoma patients treated with a personal neoantigen vaccine, NEO-PV-01, in combination with anti-PD1: A case study
38. Abstract CT125: A personal neoantigen vaccine, NEO-PV-01, with anti-PD1 induces broad de novo anti-tumor immunity in patients with metastatic melanoma, NSCLC, and bladder cancer
39. IP195. A Real-World Experience of Drug-Eluting and Non-Drug-Eluting Stents in Lower Extremity Peripheral Arterial Disease
40. An open-label, phase 1b study of NEO-PV-01 with pembrolizumab plus chemotherapy in patients with advanced or metastatic nonsquamous non-small cell lung cancer.
41. Investigating Sema6A‐PlxnA Signaling Mechanisms in Development: Identification of Key PlxnA Phosphorylation Sites and the Discovery of a Novel Naturally‐Released Sema
42. Quantifying Anesthesia Exposure in Growing Rod Treatment for Early Onset Scoliosis
43. Safety and Efficacy of Vascular Interventions Performed in a Busy Office-Based Surgery Center in Selected Patients with Low and Moderate Periprocedural Risk
44. IP217 Does Metformin Have an Effect on Stent Patency Rates?
45. PC072 Safety and Efficacy of Vascular Interventions Performed in a Busy Office-Based Surgery Center (OBSC) in Selected Patients With Low and Moderate Periprocedural Risk
46. An open-label, phase Ib study of NEO-PV-01 + adjuvant with nivolumab in patients with melanoma, non-small cell lung carcinoma, or transitional cell carcinoma of the bladder.
47. New Minimally Invasive Technique for Direct Pars Interarticularis Osteosynthesis Using Cortical Screws and Spinous-Process Modular Link
48. Randomized phase 2 trial of a coordinated breast cancer follow-up care program
49. Holbrook Kohrt: In Memoriam (1977–2016)
50. Mexiletine Prevents Recurrent Torsades de Pointes in Acquired Long QT Syndrome Refractory to Conventional Measures
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.